IRB Forum -
    The Institutional Review Board - Discussion and News Forum
Home Register Forum Links Documents Job Board News Help Sponsors Link
News
 Group receives ethics research grant to protect human subjects
Author: Eva Pastor
Date:   10-27-09 18:17

Source: mndaily.com
URL: http://www.mndaily.com/2009/10/26/group-receives-ethics-research-grant-protect-human-subjects
Date published: October 26th 2009

Group receives ethics research grant to protect human subjects
The project will tackle ethics issues involving nanomedicine.
Published: 10/26/2009
By Stacy Battenberg

A group of University of Minnesota faculty and top scholars across the nation recently began an unprecedented project that will address ethical concerns in nanomedicine research.

The project will focus on devising safeguards to protect human subjects participating in research on nanomedicine products, said Susan Wolf , the project’s principal investigator and chair of the University’s Consortium on Law and Values in Health, Environment and the Life Sciences.

Nanomedicine involves the medical application of microscope technologies built on an atomic scale.

The two-year project, which is funded by a nearly $915,000 grant from the National Institutes of Health , aims to develop the first set of comprehensive guidelines for protecting human subjects.

The goal is “to figure out what really is needed in the world of research ethics and research protections so that nanomedicine research can go forward safely,” Wolf said.

Despite the burgeoning field of research surrounding nanomedicine, many of the risks for those involved — including research subjects, scientists, lab workers and medical personnel — are still not fully understood by scientists.

“This will be the first major national project to try to wrestle that problem to the ground and come up with consensus recommendations,” Wolf said.

Efie Kokkoli, a professor of chemical engineering and material science, is involved with the research and design of targeted nanotechnologies for cancer therapeutics, including chemotherapy agents.

Nanomedicine is beneficial because of its ability to target cancer tumors, Kokkoli said, but scientists need to be sure the benefits outweigh the risks, since nanoparticles have the potential to invade healthy organs.

“You have to make sure that you are not damaging the rest of the body,” she said.

Kokkoli said the guidelines set by the project team will help eliminate some of the problems facing nanotechnology researchers by adding regulations and addressing ethical questions or issues through more oversight.

“It may make life a little bit simpler, because you will have a set of rules that you will have to follow [as a scientist],” she said.

The recommendations the project team develops will stem from information currently known and understood about the study of nanotechnology, said Ralph Hall, University law professor and co-investigator.

 Topics Author  Date
 Group receives ethics research grant to protect human subjects new 
Eva Pastor   10-27-09 18:17 


HOME | REGISTER | FORUM | LINKS | RESOURCES | JOB BOARD | NEWS | HELP | SPONSORS | CONTACT

The Center for Bioethics and Department of Medical Ethics
University of Pennsylvania School of Medicine
and
The Center for Research Integrity
The Children's Hospital of Philadelphia
© 2012 The IRB Forum. All Rights Reserved. Legal and Privacy information
Content Management by Internet Concepts.